Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
HSBC Holdings plc ( HBC - Analyst Report ) has divested its entire stake (15.6%) in Chinese insurance giant Ping An Insurance (Group) Company of China, Ltd to Thailand-based Charoen Pokphand Group for an estimated $9.4 billion (HK $72.7 billion). HSBC expects to earn a post-tax gain of $2.6 billion on the sale after deducting the carrying value of investment in Ping An and the reclassification of the connected foreign exchange and other reserves.
The divestiture will be carried out in two phases. The first stage involves transfer of 21% of the shares to the acquirer on December 7, 2012. The remaining 79% shares will be transferred on January 7, 2013, after the deal gets a nod from the Chinese regulatory authority – China Insurance Regulatory Commission. Charoen Pokphand will fund the proceeds partly in cash and partly through loan obtained from China Development Bank.
Last month, HSBC announced that it was contemplating divestiture of its stake in Ping An. Back in 2002, HSBC had initially purchased a 10% stake in Ping An for an amount of $600 million. In the period between 2002 and 2005, the company acquired another 5.6% stake in Ping An for a sum of $1.7 billion. It is noteworthy that HSBC’s 15.6% stake in the company reflects 40% of its Hong Kong-traded shares held by the former.
HSBC, under its new CEO, has resorted to aggressive restructuring since 2011. The restructuring involves streamlining its worldwide operations by shedding non-core assets to boost profitability. Ping An stake sale is a part of this strategy. Earlier this year, HSBC traded its general insurance businesses in Asia and Latin America for $914 million. The company is divesting its general insurance units in Hong Kong, Singapore, Argentina and Mexico to Australia's QBE Insurance Group Ltd. and France-based AXA Group in two separate deals.
HSBC is also looking to sell its 18% stake in Vietnamese insurer, Bao Viet Holdings. Moreover, it is assumed that eventually the company might sell its 19% stake in Bank of Communications – the fifth-largest bank in China (in terms of assets).
HSBC is not the only company disposing its non-fundamental operations. In October this year, Netherlands-based ING Groep NV ( ING - Snapshot Report ) announced the sale of its Malaysian insurance business to Asian insurance giant, AIA Group Ltd, for nearly $1.7 billion (€1.3 billion). ING also announced the divestiture of its insurance business, pension and financial planning divisions in Hong Kong and Macau, as well as its life insurance operations in Thailand to Pacific Century Group for a total of $2.14 billion (€1.64 billion) in cash.
The sluggish economic backdrop and the deepening Euro zone crisis have forced HSBC to reorganize its business strategy. We believe that these restructuring efforts will go a long way in controlling HSBC’s rising expenses and enhancing its overall profitability.
HSBC currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. Considering the fundamentals, we maintain a long-term ‘Neutral’ recommendation on the stock.
Read the full reports :
Snapshot Report on ING
Analyst Report on HBC